Applied Clinical Trials Trends / Having trouble viewing this e-mail? Click Here

In this ISSUE

Using AI & Machine Learning to Better Understand Data and Manage Risk

Latest in People and Business News

Patient Centricity Goes Global

Q&A
Big CROs Dive into Offering AI/ML Solutions
Benjamin Hughes, SVP of AI and Real–World Data at IQVIA, discusses how AI is changing the clinical trial paradigm, and how the technologies IQVIA is developing are different from other tech companies that specialize in AI/ML.
... /Read more/
Advertisement
Exclusive Video from DIA:
Overcoming Complex Challenges: Identifying eCOA and IRT Trends

Watch Video
Sponsored by: yPrime
Investigative Sites
A New Model to Support Leadership Skills of Principal Investigators
Taking a closer look at the skills expected from the Principal Investigator beyond the expected technical skills.
... /Read more/
Calendar
/ 3rdAnnual Medical Writers Summit – 9/25–9/26 /
/ 4th Annual Lay Summaries Summit — 9/25–9/26 /
/ 16th Annual Patient Summit USA – 10/2-10/3 /
/ Rare Diseases & Orphan Products Breakthrough Summit – 10/21–10/22 /

Advertisement
Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT
Register Now
Therapeutic Specific Areas
Alzheimer's Disease Research Finds New Beginnings
Dr. Daniel Alkon, President & Chief Science Officer at Neurotrope, discusses novel approaches to AD therapy development and why his company chose to target patients with advanced AD for their own.
... /Read more/
Advertisement
Begin with the End in Mind: The Strategic Benefit of Coordinating Site Budgeting, Contracting, & Payments
Wednesday, October 2, 2019 at 11am EDT
Register Now
Artificial Intelligence
How AI is Transforming Clinical Trials: A Look Into the Code
Krishnan Nandabalan, CEO of InveniAI, discusses how artificial intelligence is shifting the clinical trial paradigm in studies for areas like oncology and the central nervous system.
... /Read more/
Advertisement
Successful Early Phase Drug Development of mAb Drugs
Europe: Thursday, September 26, 2019 at 3pm BST | 4pm CEST
North America: Thursday, October 3, 2019 at 11am EDT | 10am CDT | 8am PDT
Register Now
Regulatory Affairs
Labeling Challenges from EU Annex VI
Simon Jones and Gordan Alexander, both of Prisym ID, explore the added complexity to the labeling of trial supplies that new regulations to EU 536/2014 will bring, specifically Annex VI.
... /Read more/
Ask the editor
Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise
Todd Baker
Group Publisher
tbaker@mmhgroup.com
website / blog / advertise / subscribe